Zobrazeno 1 - 10
of 757
pro vyhledávání: '"Ledbetter SR"'
Autor:
Arbeeny CM; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., Ling H; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., Smith MM; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., O'Brien S; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., Wawersik S; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., Ledbetter SR; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., McAlexander A; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., Schopfer FJ; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., Willette RN; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.)., Jorkasky DK; Sanofi, Framingham (C.M.A., M.M.S., S.R.L.), Novartis (H.L., S.O.) and Scholar Rock (S.W.), Cambridge, Massachusetts; University of Pittsburgh, Pittsburgh, Pennsylvania (F.J.S) and Complexa, Inc., Berwyn, Pennsylvania (A.M., R.N.W., D.K.J.) Diane.jorkasky@complexarx.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2019 Jun; Vol. 369 (3), pp. 503-510. Date of Electronic Publication: 2019 Mar 20.
Autor:
Yang, Po-Lung1,2 (AUTHOR), Lai, Tai-Shuan2,3 (AUTHOR), Chou, Yu-Hsiang2 (AUTHOR) chouyuhsiang@ntuh.gov.tw, Lai, Liang-Chuan4,5 (AUTHOR), Lin, Shuei-Liong2,4,6 (AUTHOR), Chen, Yung-Ming2,7 (AUTHOR)
Publikováno v:
Clinical Epigenetics. 6/15/2024, Vol. 16 Issue 1, p1-11. 11p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pozdzik AA; Laboratory of Experimental Nephrology, Department of Biochemistry, Faculty of Medicine, ULB, Brussels, Belgium.; Nephrology Department, Erasme Hospital, ULB, Brussels, Belgium., Giordano L; Laboratory of General Physiology, URPHYM, University of Namur, Namur, Belgium., Li G; CardioMetabolic and Renal Research, Cell Biology, Genzyme Corporation, Framingham, Massachusetts, United States of America., Antoine MH; Laboratory of Experimental Nephrology, Department of Biochemistry, Faculty of Medicine, ULB, Brussels, Belgium., Quellard N; Pathology and Electron Microscopy, CHU La Miletrie, Poitiers, France.; INSERM U 1082, Poitiers, France., Godet J; Pathology and Electron Microscopy, CHU La Miletrie, Poitiers, France.; INSERM U 1082, Poitiers, France., De Prez E; Laboratory of Experimental Nephrology, Department of Biochemistry, Faculty of Medicine, ULB, Brussels, Belgium., Husson C; Laboratory of Experimental Nephrology, Department of Biochemistry, Faculty of Medicine, ULB, Brussels, Belgium., Declèves AE; Laboratory of General Physiology, URPHYM, University of Namur, Namur, Belgium., Arlt VM; Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment and Health, King's College London, London, United Kingdom., Goujon JM; Pathology and Electron Microscopy, CHU La Miletrie, Poitiers, France.; INSERM U 1082, Poitiers, France., Brochériou-Spelle I; Pathology Department, Tenon Hospital, Paris, France., Ledbetter SR; CardioMetabolic and Renal Research, Cell Biology, Genzyme Corporation, Framingham, Massachusetts, United States of America., Caron N; Laboratory of General Physiology, URPHYM, University of Namur, Namur, Belgium., Nortier JL; Laboratory of Experimental Nephrology, Department of Biochemistry, Faculty of Medicine, ULB, Brussels, Belgium.; Nephrology Department, Erasme Hospital, ULB, Brussels, Belgium.
Publikováno v:
PloS one [PLoS One] 2016 Jul 05; Vol. 11 (7), pp. e0157288. Date of Electronic Publication: 2016 Jul 05 (Print Publication: 2016).
Autor:
Husson H; Department of Rare Diseases, Sanofi-Genzyme R&D Center, 49 New York Avenue, Framingham, MA 01701, USA., Moreno S; Department of Rare Diseases, Sanofi-Genzyme R&D Center, 49 New York Avenue, Framingham, MA 01701, USA., Smith LA; Department of Rare Diseases, Sanofi-Genzyme R&D Center, 49 New York Avenue, Framingham, MA 01701, USA., Smith MM; Department of Rare Diseases, Sanofi-Genzyme R&D Center, 49 New York Avenue, Framingham, MA 01701, USA., Russo RJ; Department of Rare Diseases, Sanofi-Genzyme R&D Center, 49 New York Avenue, Framingham, MA 01701, USA., Pitstick R; McLaughlin Research Institute, 1520 23rd Street South, Great Falls, Montana 59405, USA., Sergeev M; Harvard Institutes of Medicine, 4 Blackfan Circle HIM568, Boston, MA 02115, USA., Ledbetter SR; Department of Rare Diseases, Sanofi-Genzyme R&D Center, 49 New York Avenue, Framingham, MA 01701, USA., Bukanov NO; Department of Rare Diseases, Sanofi-Genzyme R&D Center, 49 New York Avenue, Framingham, MA 01701, USA., Lane M; Department of Biological Mass Spectrometry & Biomarker Research, Sanofi-Genzyme R&D Center, 1 Mountain Road, Framingham, MA 01701, USA., Zhang K; Department of Biological Mass Spectrometry & Biomarker Research, Sanofi-Genzyme R&D Center, 1 Mountain Road, Framingham, MA 01701, USA., Billot K; ManRos Therapeutics, Hotel de Recherche-Centre de Perharidy, 29680 Roscoff, France., Carlson G; McLaughlin Research Institute, 1520 23rd Street South, Great Falls, Montana 59405, USA., Shah J; Harvard Institutes of Medicine, 4 Blackfan Circle HIM568, Boston, MA 02115, USA., Meijer L; ManRos Therapeutics, Hotel de Recherche-Centre de Perharidy, 29680 Roscoff, France., Beier DR; Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, 1900 9th Avenue, Seattle, WA 98101, USA., Ibraghimov-Beskrovnaya O; Department of Rare Diseases, Sanofi-Genzyme R&D Center, 49 New York Avenue, Framingham, MA 01701, USA oxana.beskrovnaya@genzyme.com.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2016 Jun 01; Vol. 25 (11), pp. 2245-2255. Date of Electronic Publication: 2016 Apr 05.
Autor:
Rogers KA; Department of Rare Renal Disease Research, Sanofi-Genzyme R&D Center, Framingham, Massachusetts., Moreno SE; Department of Rare Renal Disease Research, Sanofi-Genzyme R&D Center, Framingham, Massachusetts., Smith LA; Department of Rare Renal Disease Research, Sanofi-Genzyme R&D Center, Framingham, Massachusetts., Husson H; Department of Rare Renal Disease Research, Sanofi-Genzyme R&D Center, Framingham, Massachusetts., Bukanov NO; Department of Rare Renal Disease Research, Sanofi-Genzyme R&D Center, Framingham, Massachusetts., Ledbetter SR; Department of Rare Renal Disease Research, Sanofi-Genzyme R&D Center, Framingham, Massachusetts., Budman Y; Department of Analytical Research and Development, Sanofi Corporation, Waltham, Massachusetts., Lu Y; Department of Biostatistics and Programming, Sanofi-Genzyme R&D Center, Framingham, Massachusetts., Wang B; Department of Analytical Research and Development, Sanofi Corporation, Waltham, Massachusetts., Ibraghimov-Beskrovnaya O; Department of Rare Renal Disease Research, Sanofi-Genzyme R&D Center, Framingham, Massachusetts., Natoli TA; Department of Rare Renal Disease Research, Sanofi-Genzyme R&D Center, Framingham, Massachusetts thomas.natoli@genzyme.com.
Publikováno v:
Physiological reports [Physiol Rep] 2016 Jun; Vol. 4 (12).
Autor:
Bracken C; Rare Diseases, Sanofi-Genzyme R&D Center, Framingham, Massachusetts; and., Beauverger P; Cardiovascular Research, Sanofi, Chilly-Mazarin, France., Duclos O; Cardiovascular Research, Sanofi, Chilly-Mazarin, France., Russo RJ; Rare Diseases, Sanofi-Genzyme R&D Center, Framingham, Massachusetts; and., Rogers KA; Rare Diseases, Sanofi-Genzyme R&D Center, Framingham, Massachusetts; and., Husson H; Rare Diseases, Sanofi-Genzyme R&D Center, Framingham, Massachusetts; and., Natoli TA; Rare Diseases, Sanofi-Genzyme R&D Center, Framingham, Massachusetts; and., Ledbetter SR; Rare Diseases, Sanofi-Genzyme R&D Center, Framingham, Massachusetts; and., Janiak P; Cardiovascular Research, Sanofi, Chilly-Mazarin, France., Ibraghimov-Beskrovnaya O; Rare Diseases, Sanofi-Genzyme R&D Center, Framingham, Massachusetts; and., Bukanov NO; Rare Diseases, Sanofi-Genzyme R&D Center, Framingham, Massachusetts; and Nikolay.Bukanov@genzyme.com.
Publikováno v:
American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2016 Jun 01; Vol. 310 (11), pp. F1414-22. Date of Electronic Publication: 2016 Apr 13.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.